Although it is well-known that metabolic disorders (such as insulin resistance, T2D and/or obesity) increase the risk for AD [38,57,71,72,73,74], the opposite (i.e., AD-induced peripheral glucose dysmetabolism and insulin insensitivity) remains a matter of debate [75,76]. This evidence concerns the gene INS and type 2 diabetes mellitus.